GlycoNex Incorporation (TPEX:4168)

GlycoNex Incorporation Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	37.86	14.7	2.54	30.09	5.48
Revenue Growth (YoY)	157.54%	478.32%	-91.55%	449.50%	1113.97%
Cost of Revenue	14.35	7.38	1.55	16.12	2.01
Gross Profit	23.51	7.32	1	13.97	3.46
Selling, General & Admin	50.94	48.89	50.48	55.2	53.38
Research & Development	222.38	204.55	210.38	197.41	145.01
Operating Expenses	273.32	253.44	260.86	252.92	198.39
Operating Income	-249.81	-246.12	-259.86	-238.95	-194.93
Interest Expense	-7.04	-3.63	-3.63	-2.75	-
Interest & Investment Income	5.7	8.1	9.37	4.59	2.74
Currency Exchange Gain (Loss)	-	3.46	-0.55	-0.48	-1.07
Other Non Operating Income (Expenses)	17.01	8.51	17.15	17.76	20.77
EBT Excluding Unusual Items	-234.13	-229.68	-237.53	-219.82	-172.49
Gain (Loss) on Sale of Assets	-	-	73.81	-	-
Pretax Income	-234.13	-229.68	-163.72	-219.82	-172.49
Income Tax Expense	1.09	0.02	14.65	-	-
Net Income	-235.23	-229.71	-178.36	-219.82	-172.49
Net Income to Common	-235.23	-229.71	-178.36	-219.82	-172.49
Shares Outstanding (Basic)	109	108	108	99	97
Shares Outstanding (Diluted)	109	108	108	99	97
Shares Change (YoY)	0.64%	0.35%	8.42%	2.49%	9.25%
EPS (Basic)	-2.16	-2.12	-1.65	-2.21	-1.78
EPS (Diluted)	-2.16	-2.12	-1.65	-2.21	-1.78
Free Cash Flow	-170.86	-253.24	-207.34	-176.24	-147.7
Free Cash Flow Per Share	-1.57	-2.34	-1.92	-1.77	-1.52
Gross Margin	62.10%	49.80%	39.14%	46.42%	63.21%
Operating Margin	-659.81%	-1674.14%	-10222.82%	-794.24%	-3560.33%
Profit Margin	-621.29%	-1562.51%	-7016.60%	-730.67%	-3150.56%
Free Cash Flow Margin	-451.29%	-1722.63%	-8156.65%	-585.80%	-2697.72%
EBITDA	-214.39	-211.74	-228.69	-198.99	-154.8
D&A For EBITDA	35.42	34.37	31.18	39.96	40.13
EBIT	-249.81	-246.12	-259.86	-238.95	-194.93

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.